FDA.reportPublic FDA data

ENEMEEZ

Manufacturer
Quest Products, LLC | Enemeez LLC DBA Summit Pharmaceuticals
Effective date
2026-06-30
Label type
HUMAN OTC DRUG LABEL
Version
20
Source
weekly-update
Hydrated at
2026-07-17 21:41:50

Label at a glance#

ProductENEMEEZ
Active ingredientDOCUSATE SODIUM
Label structure13 sections

Indications and uses

For relief of occasional constipation (irregularity). This product generally produces a bowel movement in 2 to 15 minutes.

Dosage and administration

Adults and children 12 years of age and older (with adult supervision) one to three units daily. Children under 12 years of age, consult a doctor prior to use. Twist off and remove tip. Lubricate tip prior to insertion: Place a few drops of the tube's liquid content on the shaft prior to insertion. Also apply liquid content or lubricant to the anus before inserting the mini-enema. Positioning: For best results, la...

Storage and handling

Other Information Store at room temperature 15°-30° C (59°-86° F)

Label contents#

Full prescribing information#

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

Active ingredient (per delivered dose)

Docusate Sodium USP 283 mg

Purpose

OTC - PURPOSE SECTION

Stool Softener Laxative

Uses

INDICATIONS & USAGE SECTION

  • For relief of occasional constipation (irregularity).
  • This product generally produces a bowel movement in 2 to 15 minutes.

Warnings

WARNINGS SECTION

For rectal use only. Drug Interaction Precaution: Do not take this product if you are presently taking mineral oil, unless directed by a doctor.

Do not use

OTC - DO NOT USE SECTION

  • Laxative products when abdominal pain, nausea or vomiting are present.
  • Laxative products for a period longer than 1 week unless directed by a doctor.

Stop use and ask a doctor if you have:

OTC - STOP USE SECTION

  • Rectal bleeding.
  • Noticed a sudden change in bowel habits that persists over a period of 2 weeks
  • Failed to have a bowel movement after use. This may indicate a serious condition.

OTC - PREGNANCY OR BREAST FEEDING SECTION

Pregnant or Lactating Women, ask a healthcare professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of accidental ingestion, get medical help or contact a Poison Control Center immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

Adults and children 12 years of age and older (with adult supervision) one to three units daily. Children under 12 years of age, consult a doctor prior to use.

  • Twist off and remove tip.
  • Lubricate tip prior to insertion:

Place a few drops of the tube's liquid content on the shaft prior to insertion.

Also apply liquid content or lubricant to the anus before inserting the mini-enema.

  • Positioning: For best results, lay on left side with knees bent. Insert slowly into rectum, up to the shoulder of tube.

Alternate positions: Administer while seated on the toilet. Or, kneel, then lower head and chest forward until side of face is resting on the surface.

  • With steady pressure, gently insert the tube into the rectum with care to prevent damage to the rectal wall. Squeeze to empty the contents. Keep the tube squeezed until it is removed from the rectum. After the contents have been emptied, remove the disposable tube and discard. A small amount of liquid may remain in the unit after use.

Other Information

STORAGE AND HANDLING SECTION

Other Information Store at room temperature 15°-30° C (59°-86° F)

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Glycerin USP and Polyethylene Glycol

Questions or Comments:

OTC - QUESTIONS SECTION

(888) 273-9734 or www.enemeez.com

Manufactured by:

Summit Pharmaceuticals, Inc.

Phoenix, AZ 85027

Distributed by:

Alliance Labs, LLC.

Phoenix, AZ 85027

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal Display Panels:

9876-59876-5

30count30count

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
17433-9876-0ML - Milliliter17433-98764408cdb5-7d28-4c34-8651-717075a70e4912018-05-09
17433-9876-2ML - Milliliter17433-9876fe479dae-1bb2-489e-b119-6607a33cad9912025-09-12
17433-9876-3ML - Milliliter17433-9876c1a7690a-b611-428d-8bb4-2187e4a2adc812013-02-13
17433-9876-5ML - Milliliter17433-9876944b4aa2-9468-4755-856d-4c50bf4c734812022-05-04

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
DOCUSATE SODIUMACTIVE INGREDIENTF05Q2T2JA03
DOCUSATEACTIVE MOIETYM7P27195AG3
GLYCERININACTIVE INGREDIENTPDC6A3C0OX3
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1A3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
17433-987617433-9876-0, 17433-9876-3, 17433-9876-9, 17433-9876-5, 17433-9876-6, 17433-9876-2, 17433-9876-1, 17433-9876-4

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
POLYETHYLENE GLYCOL 3005655G9Y8AQIACT
GLYCERINPDC6A3C0OXIACT
DOCUSATE SODIUMF05Q2T2JA0ACTIB

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
192026-03-25full-release2026-06-01 01:51:31

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 27 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
GLYCERINGLYCERINPDC6A3C0OXLIQUID / TOPICAL2.5 %w/wExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / ORAL2400 mgExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / ORAL2400 mgExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / TOPICAL2.5 %w/wExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / TOPICAL2.5 %w/wExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / RECTAL440 mgExact identifier — unii+route
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / TOPICAL2.5 %w/wExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / ORAL2400 mgExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / RECTAL440 mgExact identifier — unii+route
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / ORAL2400 mgExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / TOPICAL2.5 %w/wExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / RECTAL440 mgExact identifier — unii+route
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / ORAL2400 mgExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / RECTAL440 mgExact identifier — unii+route
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / TOPICAL2.5 %w/wExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / ORAL2400 mgExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / ORAL2400 mgExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / TOPICAL2.5 %w/wExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / ORAL2400 mgExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / TOPICAL2.5 %w/wExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / RECTAL440 mgExact identifier — unii+route
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / RECTAL440 mgExact identifier — unii+route
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / RECTAL440 mgExact identifier — unii+route
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / ORAL2400 mgExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / TOPICAL2.5 %w/wExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / RECTAL440 mgExact identifier — unii+route
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / RECTAL440 mgExact identifier — unii+route
27 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ENEMEEZDOCUSATE SODIUMQuest Products, LLC0b06445d-0839-497e-bdff-e0fe224a77382026-06-30WarningsExact identifier
ndc (package): 17433-9876-4
ndc (package): 17433-9876-0
ndc (package): 17433-9876-3
ndc (package): 17433-9876-2
ndc (package): 17433-9876-9
ndc (package): 17433-9876-1
ndc (package): 17433-9876-6
ndc (package): 17433-9876-5
ndc (product): 17433-9876
ndc11 (package): 17433987604
ndc11 (package): 17433987603
ndc11 (package): 17433987600
ndc11 (package): 17433987606
ndc11 (package): 17433987601
ndc11 (package): 17433987609
ndc11 (package): 17433987602
ndc11 (package): 17433987605
spl id: 557bfedd-1dff-a1ff-e063-6294a90ad7bc
spl set id: 0b06445d-0839-497e-bdff-e0fe224a7738

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.